MedPath
TGA Approval

COMIRNATY Omicron XBB.1.5 (raxtozinameran) COVID-19 VACCINE 30 micrograms/0.3 mL suspension for injection prefilled glass syringe (442810)

442810

COMIRNATY Omicron XBB.1.5 (raxtozinameran) COVID-19 VACCINE 30 micrograms/0.3 mL suspension for injection prefilled glass syringe

Pfizer Australia Pty Ltd

August 12, 2024

Medicine

Medicine

Active

Registered

Product Information

Consumer Medicine Information

https://medical-cdn.nocode.com/drug_tga/6e393674caf909bb76d5374335ba9e63.pdf

Product Information

https://medical-cdn.nocode.com/drug_tga/a3a7c889e756272030f6c7533576b6f9.pdf

Active Ingredients

raxtozinameran

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

COMIRNATY Omicron XBB.1.5 (raxtozinameran) COVID-19 VACCINE 30 micrograms/0.3 mL suspension for injection prefilled glass syringe (442810) - TGA 批准文号 | MedPath